AI assistant
Sending…
RESMED INC — Director's Dealing 2016
Apr 5, 2016
30071_dirs_2016-04-05_c33fa7c5-7544-415b-b15b-2f2b6d3ebab2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-04-04
Reporting Person: FARRELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-04 | ResMed Common Stock | M | 20000 | $25.54 | Acquired | 367978 | Direct |
| 2016-04-04 | ResMed Common Stock | S | 20000 | $57.51 | Disposed | 347978 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-04 | Resmed Stock Option Plan | $25.54 | M | 20000 | Disposed | 2016-12-17 | ResMed Common Stock (20000) | Direct |
Footnotes
F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: Represents date options first became exercisable. Options vested 1/4 per year on the anniversary of the grant.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29